PATENT CLAIM ANALYSIS

Application Number: 16012992
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "001890"]

Abstract:
Described are assay methods, modules and kits useful in the detection, treatment and/or prevention of dementia and related conditions, including but not limited to Alzheimer's disease and mild cognitive disorders.

Claim (Index 8):
The method of  claim 7  wherein said method further comprises measuring a level of at least one additional biomarker in said two or more test samples and determining from said level(s) of said first biomarker and said at least one additional biomarker the disease progression and/or efficacy of said treatment regimen for Alzheimer's-related dementia in said patient.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 94.0
- Lexical Diversity: 1.12903
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12867479', '12799484', '13874052', '14200020', '10982545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7098475141790681
- 35 USC 102 Novelty (BERT): 0.5096368388363743
- Combined Prediction Score: 0.6898264466447988
- Mean Citation Score: 253.80111
- Max Citation Score: 263.87994
- Similarity Product: 198.74821954175945

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test